Seres Therapeutics (MCRB) Misses Q1 EPS by 28c

Seres Therapeutics (NASDAQ: MCRB) reported Q1 EPS of ($0.28). Revenue for the quarter came in at $360 thousand.

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

You May Also Be Interested In

• NeoVolta Inc. (NEOV) Misses Q3 EPS by 17c
• AMC Entertainment prices $2.85B in new debt to refinance existing loans
• Visa deposits $405M into U.S. litigation escrow, adjusting stock rates